Mithra Pharmaceuticals (XBRU:MITRA) Other Net Income (Loss) : €-0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Mithra Pharmaceuticals Other Net Income (Loss)?

Mithra Pharmaceuticals's Other Net Income (Loss) for the six months ended in Jun. 2023 was €0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.00 Mil.

Mithra Pharmaceuticals's quarterly Other Net Income (Loss) declined from Jun. 2022 (€0.00 Mil) to Dec. 2022 (€-0.00 Mil) but then increased from Dec. 2022 (€-0.00 Mil) to Jun. 2023 (€0.00 Mil).

Mithra Pharmaceuticals's annual Other Net Income (Loss) declined from Dec. 2020 (€0.00 Mil) to Dec. 2021 (€-0.00 Mil) and declined from Dec. 2021 (€-0.00 Mil) to Dec. 2022 (€-0.00 Mil).

Mithra Pharmaceuticals Other Net Income (Loss) Historical Data

The historical data trend for Mithra Pharmaceuticals's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mithra Pharmaceuticals Other Net Income (Loss) Chart

Mithra Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Net Income (Loss)

Get a 7-Day Free Trial

15.24

Mithra Pharmaceuticals Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Mithra Pharmaceuticals Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.00 Mil.

Mithra Pharmaceuticals Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Mithra Pharmaceuticals's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Mithra Pharmaceuticals (XBRU:MITRA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mithra Pharmaceuticals SA (XBRU:MITRA) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

0R91:UK 1TM:Germany

Address

Rue Saint-Georges 5, Liege, BEL, 4000

Website

https://www.mithra.com

Mithra Pharmaceuticals SA develops products for women's health with a particular focus on fertility, contraception, and menopause. It operates in three segments: Product Sales, Out-licensing, and Other. The company also develops and markets complex therapeutic solutions and offers partners a complete spectrum of research, development, and specialist manufacturing at its Mithra CDMO. Its geographical segments are Belgium, Europe and Outside Europe.

Mithra Pharmaceuticals (XBRU:MITRA) Headlines

No Headlines